 |
 |
top viewed article of the day |
Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker George L. Bakris, MD
Fixed-dosed combination regimens consisting of a calcium channel blocker and an angiotensin II type 1 receptor blocker represent a new addition to the available antihypertensive treatment options. Clinical trials demonstrate that both the dihydropyridine calcium channel blocker amlodipine and angiotensin II receptor blockers are effective agents for the management of hypertension in individuals with or without cardiovascular disease. When combined, these 2 classes of agents have complementary effects on blood pressure, as each targets separate signaling pathways in the vasculature pivotal to the regulation of vascular function. In clinical trials this combination has demonstrated better efficacy, defined by time to reach blood pressure targets as well as levels of blood pressure achieved, compared with the individual agents. In a comparative trial, a combination of amlodipine plus valsartan (an angiotensin II receptor blocker) also produced greater reductions in blood pressure compared with a combination of lisinopril (an angiotensin-converting enzyme inhibitor) and hydrochlorothiazide. The combination of amlodipine and an angiotensin II receptor blocker is well tolerated, including in patients with stage 2 hypertension and the elderly.
(J Clin Hypertens (Greenwich). 2008;10(1 suppl 1):27–32)
|
| J Clin Hypertens(2008) 10;1 Suppl 1:27-32 |
|
 |
|
| latest NO FEE INSTANT CME courses |
Obstructive Sleep Apnea and Hypertension
The Journal of Clinical Hypertension®
|
1.0 AMA/PRA Credit |
Improving Blood Pressure Control: Increase the Dose of Diuretic or Switch to a Fixed-Dose Angiotensin Receptor Blocker/Diuretic? The Valsartan Hydrochlorothiazide Diuretic for Initial Control and Titration to Achieve Optimal Therapeutic Effect (Val-DICTATE) Trial
The Journal of Clinical Hypertension®
|
1.0 AMA/PRA Credit |
Varenicline and Its Role in Smoking Cessation
Preventive Cardiology™
|
1.0 AMA/PRA Credit |
Salt-Resistant and Salt-Sensitive Phenotypes Determine the Sensitivity of Blood Pressure to Weight Loss in Overweight/Obese Patients
The Journal of Clinical Hypertension®
|
1.0 AMA/PRA Credit |
Challenges to the Diagnosis, Evaluation, Treatment and Management of Clustered Cardiometabolic Risk Factors
Journal of the CardioMetabolic Syndrome
|
1.0 AMA/PRA Credit |
| Enter our Manuscript Submission System |
 |
| Employment Opportunities |
 |
|
 |
 |
 |
 |
FULL TEXT SEARCH [BETA 0.3] |
 |
ADVANCED SEARCH OPTIONS |
 |
The American Heart Hospital Journal
Winter 2008
|
 |
The American Journal of Geriatric Cardiology
March/April 2008
|
 |
Congestive Heart Failure
July/August 2008
|
 |
Journal of the Cardiometabolic Syndrome
Spring 2008
|
 |
The Journal of Clinical Hypertension
August 2008
|
 |
Preventive Cardiology
Summer 2008
|
 |
SKINmed: Dermatology for the Clinician
March/April 2008
|
|
 |
 |
 |
|
|
 |